2023 Was a troublesome yr for that biopharma business, with many corporations downsizing and restructuring their workforces to remain afloat. You'll find signs of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and daily life sciences marketplace during the latter Element of 2023 and have ongoing their upswing https://sites.google.com/view/bio-sites/blog